Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Z0EH
|
||||
| Former ID |
DIB009038
|
||||
| Drug Name |
PheTQS
|
||||
| Synonyms |
PheTQS; Alpha7 nicotinic acetylcholine receptor positive allosteric modulators (PAMs) (CNS disorders), GlaxoSmithKline; Alpha7 nicotinic acetylcholine receptor positive allosteric modulators (PAMs) (CNS disorders), Proximagen
|
||||
| Indication | Central nervous system disease [ICD10:G00-G99] | Investigative | [543845] | ||
| Company |
GlaxoSmithKline plc
|
||||
| Canonical SMILES |
c1(ccc2c(c1)[C@@H]1[C@H]([C@H](N2)c2ccc(cc2)C)CC=C1)S(=<br />O)(=O)N
|
||||
| Target and Pathway | |||||
| Target(s) | Neuronal acetylcholine receptor protein, alpha-7 chain | Target Info | Modulator | [543845] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.